Australian regulator TGA warns of ‘rare but severe’ eye disorder linked to GLP-1 drugs like Ozempic

Sources

Coverage

Limited spectrum

Sentiment

+0.10

◀ Left 100%Centre 0%Right 0% ▶

How we rate bias →

This story is currently only covered by one source from a single part of the political spectrum. NewsDeck will update this page automatically if other outlets pick up the story.

shopping_bagDAB Radio

Catch live political coverage and debate shows without needing a screen.

Browse DAB radios on Amazonarrow_forward

NewsDeck Poll

Do you think this story is being covered fairly across the political spectrum?

Loading…

Left

(1)

Guardian World

Neutral

Australian regulator TGA warns of ‘rare but severe’ eye disorder linked to GLP-1 drugs like Ozempic

TGA says product information for some diabetes and weight loss drugs updated with warning of NAION disorder Follow our Australia news live blog for latest updates Get our breaking news email, free app or daily news podcast Australia’s medicines regulator has issued warnings for several type 2 diabetes and obesity-related treatments – including Ozempic and Mounjaro – over the potential to cause a “rare but severe” …